Skip to content

World of DTC Marketing.com

Healthcare is changing by necessity
Main navigation
  • Home
  • Stats & Facts
  • Health Facts & Stats
  • About Me

BMS Celgene Merger

BMS: Delayed new drug to avoid paying billions?

W W Read More

Bristol Myers Squibb Co was sued for $6.4 billion on Thursday for allegedly delaying its Breyanzi cancer drug to avoid payments to shareholders of the former Celgene Corp, which the drugmaker bought in 2019. Was it a wise move or incompetence?

Continue reading →
Posted on February 25, 2022February 25, 2022 Business of the drug industry
© 2023 World of DTC Marketing.com. Made with love by Pixelgrade
  • Home
  • About Me
  • Health Facts & Stats
  • Stats & Facts
Secondary navigation
  • Search

Begin typing your search above and press return to search. Press Esc to cancel.